Update on the Status of Medication Abortion and the Courts April 21, 2023 Blog This policy watch explains the April 21, 2023 United States Supreme Court’s ruling on Alliance for Hippocratic Medicine v. FDA, a case challening the FDA’s approval of mifepristone, the medication abortion pill.
Q & A: Implications of Two Conflicting Federal Court Rulings on the Availability of Medication Abortion and the FDA’s Authority to Regulate Drugs April 8, 2023 Blog This policy watch explains the two conflicting rulings on the provision of mifepristone issued by two separate District Courts on April 7, 2023, Alliance for Hippocratic Medicine v. FDA and State of Washington v. United States Food and Drug Administration.
Q&A: Implications of the Ruling on the ACA’s Preventive Services Requirement April 4, 2023 Blog This post summarizes some of the key issues related to the U.S. District Court’s March 30 ruling in Braidwood Management v. Becerra, which imposes new limits on the government’s ability to enforce preventive service requirements nationwide.
Who Uses Telecontraception and Why? A Closer Look at Clients of Four Telecontraception Companies April 4, 2023 Issue Brief Based on the findings of a nonprobability sample of 6,000 survey respondents from four telecontraception companies, this brief presents a snapshot of telecontraception users and their reasons for using these platforms.
Legal Challenges to the FDA Approval of Medication Abortion Pills March 13, 2023 Issue Brief This issue brief details the Alliance of Hippocratic Medicine challenge to the FDA’s approval of the abortion pill, mifepristone. It provides context for the challenge, as well as what some of the possible rulings in the case could mean for access to medication abortion.
Women’s Experiences with Provider Communication and Interactions in Health Care Settings: Findings from the 2022 KFF Women’s Health Survey February 22, 2023 Issue Brief This brief presents findings from the 2022 KFF Women’s Health Survey (WHS) on women’s experiences with the health care system including screening for social determinants of health, provider communication and interactions, and discrimination.
Many Women Use Preventive Services, but Gaps in Awareness of Insurance Coverage Requirements Persist: Findings from the 2022 KFF Women’s Health Survey February 22, 2023 Issue Brief This brief presents findings from the 2022 KFF Women’s Health Survey on women’s receipt of cancer screenings and other preventive services and differences between subgroups of women. We also present data on women’s and men’s awareness of federal requirements for private insurance coverage of preventive services.
Nearly Half of Young Women Report Negative Interactions with Health Care Providers February 22, 2023 News Release Among women ages 18-35 with a clinical visit in the past two years, more than four in 10 (46%) report experiencing a negative interaction with a health care provider, according to a new analysis of 2022 KFF Women’s Health Survey (WHS) data. These interactions included a provider either dismissing patients’…
Legal Challenges to State Abortion Bans Since the Dobbs Decision January 20, 2023 Issue Brief This issue brief presents an overview of the legal challenges presented in state courts since the Dobbs ruling in June 2022 and highlights some of the novel strategies that are being used to defend access to abortion in states that have enacted abortion bans.
Large Shares of Women Report Needing Mental Health Services but Many Don’t Get Them December 20, 2022 News Release An analysis of 2022 KFF Women’s Health Survey (WHS) data finds that although large shares of women report needing mental health services over the past two years, a significant percentage did not access services they felt they needed. Fifty percent of women ages 18-64 say they needed mental health services…
